1. Rivera G, Pinkel D, Simone JV, Hancock ML, Crist WM . Treatment of acute lymphoblastic leukemia. 30 yrs' experience at St Jude Children's Research Hospital. N Engl J Med 1993; 329: 1289–1295.
2. Van der Does-van den Berg A, Veerman AJP, van Wering ER, de Vries JA, de Waal FC, van Zanen GE et al. Childhood acute lymphoblastic leukemia in the Netherlands. Randomized studies and nationwide treatment results from 1972 to 1995. Int J Ped Hematol Oncol 1998; 52: 125–139.
3. Van der Does-van den Berg A, van Wering ER, Suciu S, Solbu G, van 't Veer MB, Rammeloo JA et al. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). Am J Pediatr Hematol Oncol 1989; 11: 125–133.
4. Kamps WA, Veerman AJ, van Wering ER, van Weerden JF, Slater R, van der Does-van den Berg A . Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991. Leukemia 2000; 14: 2240–2246.
5. Veerman AJP, Hählen K, Kamps WA, van Leeuwen EF, de Vaan GAM, Solbu G et al. High cure rate with a moderately intensive treatment regimen in non-high risk childhood acute lymphoblastic leukemia: results of protocol ALL IV from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996; 14: 911–918.